SCHEMBL236266

SCHEMBL236266

NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.66
ALOX15 P16050 1/20 0.66
BLM P54132 1/20 0.66
PMP22 Q01453 1/20 0.66
NOD1 Q9Y239 12/20 0.60
PTGS1 P23219 1/20 0.52
GSTK1 Q9Y2Q3 1/20 0.52
FOLH1 Q04609 2/20 0.52
GLO1 Q04760 1/20 0.49
GRM8 O00222 1/20 0.47
GRM6 O15303 1/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GSR P00390 1/20 0.47
CYP1A2 P05177 1/20 0.47
GRIK1 P39086 1/20 0.47
GRM5 P41594 1/20 0.47
GRIA1 P42261 1/20 0.47
GRIA2 P42262 1/20 0.47
GRIA3 P42263 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL236265 1.00 KMT2A (0.66) KMT2AALOX15BLMPMP22NOD1
SCHEMBL12964807 1.00 KMT2A (0.66) KMT2AALOX15BLMPMP22NOD1
SCHEMBL1983785 1.00 KMT2A (0.66) KMT2AALOX15BLMPMP22NOD1
Glutamine SCHEMBL28063133 0.90 KMT2A (0.61) KMT2AALOX15BLMPMP22NOD1
SCHEMBL31132130 0.90 NOD1 (0.56) KMT2AALOX15BLMPMP22NOD1
SCHEMBL31132157 0.90 NOD1 (0.56) KMT2AALOX15BLMPMP22NOD1
SCHEMBL31132142 0.90 NOD1 (0.56) KMT2AALOX15BLMPMP22NOD1
SCHEMBL9688034 0.88 FOLH1 (0.64) NOD1PTGS1GSTK1FOLH1GLO1
SCHEMBL236257 0.88 FOLH1 (0.64) NOD1PTGS1GSTK1FOLH1GLO1
SCHEMBL1769459 0.88 FOLH1 (0.64) NOD1PTGS1GSTK1FOLH1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709912-A1 PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS BioAtla, Inc. (US) 2026-03-18 EP claimed
CN-118737430-B Methods, devices, media, and program products for predicting VHL syndrome kidney cancer based on DAMs 北京大学第一医院(北京大学第一临床医学院) 2025-06-24 CN claimed
WO-2025123045-A1 PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2025-06-12 WO claimed
CN-113330022-B Peptides having antioxidant activity and compositions comprising the same 泉标食品有限公司 2025-03-11 CN claimed
WO-2024232976-A1 PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS BIOATLA, INC. (US) 2024-11-14 WO claimed
CN-118538425-B Diagnosis model of VHL syndrome kidney cancer and application thereof 北京大学第一医院(北京大学第一临床医学院) 2024-10-29 CN claimed
EP-3969903-B1 METHOD OF SELECTING SKIN TREATMENT REGIMENS, INGREDIENTS AND COMPOSITIONS JOHNSON & JOHNSON CONSUMER INC (US) 2024-10-09 EP claimed
CN-118737430-A Methods, devices, media, and program products for predicting VHL syndrome kidney cancer based on DAMs 北京大学第一医院(北京大学第一临床医学院) 2024-10-01 CN claimed
CN-118538425-A Diagnosis model of VHL syndrome kidney cancer and application thereof 北京大学第一医院(北京大学第一临床医学院) 2024-08-23 CN claimed
US-12050228-B2 Automated sample quality assessment METABOLON, INC. (US) 2024-07-30 US claimed
CN-106537145-A Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment 麦特博隆股份有限公司 2017-03-22 CN claimed
EP-3129909-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT Metabolon, Inc. (US) 2017-02-15 EP claimed
WO-2015157407-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT METABOLON, INC. (US) 2015-10-15 WO claimed
EP-2813580-A1 Biomarkers related to metabolic age and methods using the same Metabolon, Inc. (US) 2014-12-17 EP claimed
US-20130121918-A1 Nano-Hybrid Delivery System for Sequential Utilization of Passive and Active Targeting THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-05-16 US claimed
WO-2011133617-A1 NANO-HYBRID DELIVERY SYSTEM FOR SEQUENTIAL UTILIZATION OF PASSIVE AND ACTIVE TARGETING THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2011-10-27 WO claimed
EP-2262537-A1 POLYMER PACLITAXEL CONJUGATES AND METHODS FOR TREATING CANCER Nitto Denko Corporation (JP) 2010-12-22 EP claimed
WO-2009111271-A1 POLYMER PACLITAXEL CONJUGATES AND METHODS FOR TREATING CANCER NITTO DENKO CORPORATION (JP) 2009-09-11 WO claimed
US-20090226393-A1 POLYMER PACLITAXEL CONJUGATES AND METHODS FOR TREATING CANCER NITTO DENKO CORPORATION (JP) 2009-09-10 US claimed
EP-0559175-B1 gamma-Polyglutamate hydrolase and process for producing same MEIJI SEIKA KAISHA (JP) 1999-07-14 EP claimed